Please use this identifier to cite or link to this item: https://repository.iimb.ac.in/handle/2074/21663
DC FieldValueLanguage
dc.contributor.advisorDasgupta, Kunal
dc.contributor.authorMondal, Piyush
dc.contributor.authorBhesdadiya, Anand Bharatkumar
dc.date.accessioned2022-10-24T12:10:47Z-
dc.date.available2022-10-24T12:10:47Z-
dc.date.issued2021
dc.identifier.urihttps://repository.iimb.ac.in/handle/2074/21663-
dc.description.abstractIndian pharma industry is predicted to cross market valuation of US $130 bn. by 2030. India seems a huge market ranking 3'd globally in production by volume and 14'h by value. There are 3000 drug companies & more than 10000 manufacturing fim1s in the subcontinent; offering India a strong standing worldwide. In terms of exports, India stands at US$ 20.70 bn. in FY 20 and US$ 24.44 bn. in FY 21. The growth rate of this sector is also very impressive with CAGR of 22.4% in the coming years. Moreover, India has the 2nd highest manpower employed in biotech & pharma industry worldwide. The rise of healthcare and biotech industry serves as a perfect complementary for this already att ractive sector.
dc.publisherIndian Institute of Management Bangalore
dc.relation.ispartofseriesPGP_CCS_P21_157
dc.subjectPharmaceutical industry
dc.subjectMarkets
dc.subjectTrade
dc.titleStudy on pharma sector, exports: Analysing African markets and trade conditions
dc.typeCCS Project Report-PGP
dc.pages31p.
Appears in Collections:2021
Files in This Item:
File SizeFormat 
PGP_CCS_P21_157.pdf4.64 MBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.